Concert Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-9,163
Closed -$224K 1032
2016
Q2
$224K Sell
9,163
-2,718
-23% -$77.1K 0.03% 564
2016
Q1
$399K Buy
11,881
+782
+7% +$24.6K 0.05% 395
2015
Q4
$331K Buy
11,099
+1,211
+12% +$40.8K 0.04% 450
2015
Q3
$313K Buy
+9,888
New +$482K 0.04% 467

Other funds holding PGEN

Concert Wealth Management's PGEN Position: Q3 2016 in Review

Concert Wealth Management sold out of Precigen (PGEN) in Q3 2016, closing a stake of 9,163 shares — an estimated $224K sold.

Concert Wealth Management first reported a position in PGEN in Q3 2015 and held it in 4 quarters. The position peaked at $399K in Q1 2016. 168 funds tracked by Wall St. Rank hold PGEN as of Q3 2016.

  • Concert Wealth Management reported no remaining Precigen position as of Q3 2016 after selling out during the quarter.
  • Concert Wealth Management sold 9,163 Precigen shares in Q3 2016, an estimated $224K.
  • Concert Wealth Management first reported a position in Precigen in Q3 2015 and held it in 4 quarters.
  • Concert Wealth Management's Precigen position peaked at $399K in Q1 2016.
  • 168 funds tracked by Wall St. Rank held Precigen as of Q3 2016.

Based on Concert Wealth Management's 13F filing for Q3 2016, filed 27 Oct 2016.